These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3079939

  • 1. Nitroglycerin lingual spray: clinical efficacy and dose-response relation.
    Parker JO, Vankoughnett KA, Farrell B.
    Am J Cardiol; 1986 Jan 01; 57(1):1-5. PubMed ID: 3079939
    [Abstract] [Full Text] [Related]

  • 2. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.
    Parker JO, Vankoughnett KA, Farrell B.
    Am J Cardiol; 1985 Nov 01; 56(12):724-8. PubMed ID: 3933317
    [Abstract] [Full Text] [Related]

  • 3. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
    Sato H, Koretsune Y, Taniguchi T, Fukui S, Shimazu T, Sugii M, Matsuyama T, Karita M, Hori M.
    Arzneimittelforschung; 1997 Feb 01; 47(2):128-31. PubMed ID: 9079231
    [Abstract] [Full Text] [Related]

  • 4. Determination of the optimal dose of glyceryl trinitrate in the treatment of stable angina.
    Mannering D, Kemp AL, Bennett ED.
    Eur Heart J; 1987 Jul 01; 8(7):744-7. PubMed ID: 3115779
    [Abstract] [Full Text] [Related]

  • 5. Transdermal nitroglycerin in angina pectoris.
    Parker JO, Fung HL.
    Am J Cardiol; 1984 Sep 01; 54(6):471-6. PubMed ID: 6433687
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
    Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH.
    J Am Coll Cardiol; 2002 Apr 03; 39(7):1199-203. PubMed ID: 11923046
    [Abstract] [Full Text] [Related]

  • 8. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
    Rezaković DE, Pavicić L, Majacić M.
    Eur Heart J; 1988 Jan 03; 9 Suppl A():73-81. PubMed ID: 3137073
    [Abstract] [Full Text] [Related]

  • 9. Antianginal efficacy of a new nitroglycerin patch.
    Parker JO.
    Eur Heart J; 1989 May 03; 10 Suppl A():43-9. PubMed ID: 2501094
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R, D'Alterio D, Schiattarella M, Boccia A, Greco L, Marsico F.
    Am J Cardiol; 1988 Mar 25; 61(9):44E-51E. PubMed ID: 3126635
    [Abstract] [Full Text] [Related]

  • 11. Haemodynamic, anti-anginal and anti-ischaemic effects of sublingual nitroglycerin: dose-response, duration and time of onset of action.
    Nyberg G, Holmberg B.
    Eur J Clin Pharmacol; 1988 Mar 25; 34(6):561-7. PubMed ID: 3139428
    [Abstract] [Full Text] [Related]

  • 12. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Parker JO, VanKoughnett KA, Fung HL.
    Am J Cardiol; 1984 Jul 01; 54(1):8-13. PubMed ID: 6430057
    [Abstract] [Full Text] [Related]

  • 13. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.
    Sullivan M, Savvides M, Abouantoun S, Madsen EB, Froelicher V.
    J Am Coll Cardiol; 1985 May 01; 5(5):1220-3. PubMed ID: 3921585
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
    Longobardi G, Ferrara N, Leosco D, Abete P, Furgi G, Cacciatore F, Corbi G, Pescatore R, Rengo F.
    Cardiovasc Drugs Ther; 2004 Sep 01; 18(5):363-70. PubMed ID: 15717138
    [Abstract] [Full Text] [Related]

  • 15. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE, Lakatos S, Stalec J, Pavicić L.
    Z Kardiol; 1986 Sep 01; 75 Suppl 3():90-5. PubMed ID: 3099489
    [Abstract] [Full Text] [Related]

  • 16. Effects of sublingual nitroglycerin on the gas exchange response to exercise in stable angina pectoris.
    Sullivan M, Myers J, Buchanan N, Froelicher V.
    Am J Cardiol; 1993 Oct 01; 72(11):767-9. PubMed ID: 8213507
    [Abstract] [Full Text] [Related]

  • 17. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS, Dang NS, Reynolds RD.
    Clin Ther; 1985 Oct 01; 7(6):674-9. PubMed ID: 3935313
    [Abstract] [Full Text] [Related]

  • 18. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.
    Carù B, Pirelli S, Ferratini M, Gasparini M, Cattafi G, Corrada E, Pollavini P.
    Eur Heart J; 1988 Jan 01; 9 Suppl A():105-11. PubMed ID: 3137062
    [Abstract] [Full Text] [Related]

  • 19. The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study.
    Nyberg G.
    Eur Heart J; 1985 Jul 01; 6(7):625-30. PubMed ID: 3930248
    [Abstract] [Full Text] [Related]

  • 20. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
    Frishman WH, Giles T, Greenberg S, Heiman M, Raffidal L, Soberman J, Laifer L, Nadelmann J, Lazar E, Strom J.
    J Clin Pharmacol; 1989 Dec 01; 29(12):1097-105. PubMed ID: 2515215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.